參考文獻 |
1. Bernstein, B.E., A. Meissner, and E.S. Lander, The mammalian epigenome. Cell, 2007. 128(4): p. 669-81.
2. Poynard, T., et al., Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology, 1996. 24(4): p. 778-89.
3. Yano, M., et al., The long-term pathological evolution of chronic hepatitis C. Hepatology, 1996. 23(6): p. 1334-40.
4. Seeff, L.B., et al., Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med, 1992. 327(27): p. 1906-11.
5. Dusheiko, G.M. and J.A. Roberts, Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology, 1995. 22(6): p. 1863-73.
6. Holliday, R., The inheritance of epigenetic defects. Science, 1987. 238(4824): p. 163-70.
7. Esteller, M., Epigenetics in cancer. N Engl J Med, 2008. 358(11): p. 1148-59.
8. Reik, W., Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 2007. 447(7143): p. 425-32.
9. Beck, S. and V.K. Rakyan, The methylome: approaches for global DNA methylation profiling. Trends Genet, 2008. 24(5): p. 231-7.
10. Bird, A.P., CpG-rich islands and the function of DNA methylation. Nature, 1986. 321(6067): p. 209-13.
11. Fuks, F., DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev, 2005. 15(5): p. 490-5.
12. Baldi, P.a.H., G. W., DNA microarrays and gene expression: From experiments to data analysis and modeling. Cambridge University Press, 2002.
13. AFFYMETRIX, Array Design for the GeneChip® Human Genome U133 Set.
14. Brazma, A., et al., Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet, 2001. 29(4): p. 365-71.
15. Knudsen, T.B. and G.P. Daston, MIAME guidelines. Reprod Toxicol, 2005. 19(3): p. 263.
16. Brazma, A., Minimum Information About a Microarray Experiment (MIAME)--successes, failures, challenges. ScientificWorldJournal, 2009. 9: p. 420-3.
17. Mas, V.R., et al., Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med, 2009. 15(3-4): p. 85-94.
18. AFFYMETRIX, Design and Performance of the GeneChip® Human Genome U133 Plus 2.0 and Human Genome U133A 2.0 Arrays.
19. Bolstad, B.M., et al., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 2003. 19(2): p. 185-93.
20. Dennis, G., Jr., et al., DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol, 2003. 4(5): p. P3.
21. Huang da, W., B.T. Sherman, and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 2009. 4(1): p. 44-57.
22. Yang, B., et al., Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol, 2003. 163(3): p. 1101-7.
23. Wang, S.N., et al., Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol, 2006. 59(9): p. 930-4.
|